Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jin S Im

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2005
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramidesKarl O A Yu, Jin S Im, Alberto Molano, et al.
Immunity|June 10, 2008
pH-dependent interdomain tethers of CD1b regulate its antigen captureMiguel Relloso, Tan-Yun Cheng, Jin S Im, et al.
Plos One|December 24, 2010
Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agentsGabriel Bricard, Manjunatha M Venkataswamy, Karl O A Yu, et al.
Frontiers in Immunology|February 5, 2019
A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2Amanda C Herrmann, Jin S Im, Sumedha Pareek, et al.
Cytotherapy|August 5, 2018
Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host diseaseAbel Trujillo-Ocampo, Hyun-Woo Cho, Amanda C Herrmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumorsGabriel Bricard, Valerie Cesson, Estelle Devevre, et al.
Clinical Immunology (Orlando, Fla.)|March 1, 2008
Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infectionsJin S Im, Tae-Jin Kang, Seong-Beom Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2023
Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic SyndromesSung-Eun Lee, Feng Wang, Maison Grefe, et al.
The American Journal of Surgical Pathology|August 24, 2017
Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host DiseaseJin S Im, Susan C Abraham, Rima M Saliba, et al.
Bone Marrow Transplantation|September 28, 2018
Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndromePiyanuch Kongtim, Simrit Parmar, Denái R Milton, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2005
Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramidesKarl O A Yu, Jin S Im, Alberto Molano, et al.
Immunity|June 10, 2008
pH-dependent interdomain tethers of CD1b regulate its antigen captureMiguel Relloso, Tan-Yun Cheng, Jin S Im, et al.
Plos One|December 24, 2010
Α-galactosylceramide analogs with weak agonist activity for human iNKT cells define new candidate anti-inflammatory agentsGabriel Bricard, Manjunatha M Venkataswamy, Karl O A Yu, et al.
Frontiers in Immunology|February 5, 2019
A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2Amanda C Herrmann, Jin S Im, Sumedha Pareek, et al.
Cytotherapy|August 5, 2018
Rapid ex vivo expansion of highly enriched human invariant natural killer T cells via single antigenic stimulation for cell therapy to prevent graft-versus-host diseaseAbel Trujillo-Ocampo, Hyun-Woo Cho, Amanda C Herrmann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
Enrichment of human CD4+ V(alpha)24/Vbeta11 invariant NKT cells in intrahepatic malignant tumorsGabriel Bricard, Valerie Cesson, Estelle Devevre, et al.
Clinical Immunology (Orlando, Fla.)|March 1, 2008
Alteration of the relative levels of iNKT cell subsets is associated with chronic mycobacterial infectionsJin S Im, Tae-Jin Kang, Seong-Beom Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2023
Immunologic Predictors for Clinical Responses during Immune Checkpoint Blockade in Patients with Myelodysplastic SyndromesSung-Eun Lee, Feng Wang, Maison Grefe, et al.
The American Journal of Surgical Pathology|August 24, 2017
Histologic Grade 1 Is Associated With Increased Nonrelapsed Mortality in Lower Gastrointestinal Graft Versus Host DiseaseJin S Im, Susan C Abraham, Rima M Saliba, et al.
Bone Marrow Transplantation|September 28, 2018
Impact of a novel prognostic model, hematopoietic cell transplant-composite risk (HCT-CR), on allogeneic transplant outcomes in patients with acute myeloid leukemia and myelodysplastic syndromePiyanuch Kongtim, Simrit Parmar, Denái R Milton, et al.
Pageof 5